anmelden
SXI Life Sciences
7.772,36
PKT
-3,32
PKT
-0,04
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 22.08.12 | Straumann neutral | UBS AG | |
| 22.08.12 | Straumann neutral | Nomura | |
| 22.08.12 | Straumann underperform | Cheuvreux SA | |
| 22.08.12 | Straumann underperform | Exane-BNP Paribas SA | |
| 22.08.12 | Straumann hold | Vontobel Research | |
| 21.08.12 | Straumann neutral | Sarasin Research | |
| 21.08.12 | COLTENE hold | Vontobel Research | |
| 20.08.12 | Novartis neutral | Goldman Sachs Group Inc. | |
| 17.08.12 | Straumann neutral | Nomura | |
| 17.08.12 | Tecan (N) buy | UBS AG | |
| 17.08.12 | Tecan (N) hold | Vontobel Research | |
| 17.08.12 | Basilea Pharmaceutica hold | Vontobel Research | |
| 17.08.12 | COLTENE hold | Vontobel Research | |
| 16.08.12 | Basilea Pharmaceutica buy | Sarasin Research | |
| 16.08.12 | Basilea Pharmaceutica hold | Vontobel Research | |
| 16.08.12 | Tecan (N) hold | Vontobel Research | |
| 16.08.12 | Novartis outperform | Sanford C. Bernstein and Co., Inc. | |
| 15.08.12 | Novartis buy | Nomura | |
| 14.08.12 | Straumann hold | Vontobel Research | |
| 10.08.12 | Straumann underperform | Exane-BNP Paribas SA | |
| 10.08.12 | Lonza neutral | J.P. Morgan Cazenove | |
| 30.07.12 | Novartis hold | Vontobel Research | |
| 26.07.12 | Lonza neutral | UBS AG | |
| 26.07.12 | Straumann neutral | UBS AG | |
| 26.07.12 | Lonza hold | Vontobel Research | |
| 26.07.12 | BB Biotech | Close Brothers Seydler Research AG | |
| 25.07.12 | Lonza neutral | Sarasin Research | |
| 25.07.12 | Novartis buy | Nomura | |
| 25.07.12 | Novartis kaufen | Sarasin Research | |
| 25.07.12 | Lonza hold | Vontobel Research | |
| 23.07.12 | Basilea Pharmaceutica hold | Vontobel Research | |
| 23.07.12 | Novartis hold | Vontobel Research | |
| 23.07.12 | Novartis outperform | Sanford C. Bernstein and Co., Inc. | |
| 20.07.12 | Novartis buy | Société Générale Group S.A. (SG) | |
| 20.07.12 | BB Biotech halten | Independent Research GmbH | |
| 20.07.12 | Novartis kaufen | Hamburger Sparkasse AG (Haspa) | |
| 20.07.12 | Novartis hold | Vontobel Research | |
| 20.07.12 | Novartis neutral | Exane-BNP Paribas SA | |
| 19.07.12 | Novartis halten | Independent Research GmbH | |
| 19.07.12 | Novartis buy | Sarasin Research |
